Literature DB >> 27298722

Profound hyperkalemia associated with thromboprophylactic enoxaparin.

Michael Joseph Scalese1.   

Abstract

Entities:  

Year:  2016        PMID： 27298722      PMCID： PMC4892404          DOI： 10.1177/2042098616638076

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  6 in total

1.  Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study.

Authors:  Olga H Torres; Nerea Hernandez; Esther Francia; Montserrat Barcelo; Jose Mateo; Domingo Ruiz
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin.

Authors:  Christine Danguy; Patrick Biston; Eric Carlier; Pierre Defrance; Michael Piagnerelli
Journal:  Intensive Care Med       Date:  2012-08-08       Impact factor: 17.440

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 5.  Heparin-induced aldosterone suppression and hyperkalemia.

Authors:  J R Oster; I Singer; L M Fishman
Journal:  Am J Med       Date:  1995-06       Impact factor: 4.965

6.  Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels.

Authors:  Girish M Bengalorkar; N Sarala; P N Venkatrathnamma; T N Kumar
Journal:  J Pharmacol Pharmacother       Date:  2011-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.